Antibiotics-Basel最新文献

筛选
英文 中文
Commercial Silver-Based Dressings: In Vitro and Clinical Studies in Treatment of Chronic and Burn Wounds. 商用银基敷料:治疗慢性和烧伤伤口的体外和临床研究。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-23 DOI: 10.3390/antibiotics13090910
Sweta Shrestha, Bo Wang, Prabir K Dutta
{"title":"Commercial Silver-Based Dressings: In Vitro and Clinical Studies in Treatment of Chronic and Burn Wounds.","authors":"Sweta Shrestha, Bo Wang, Prabir K Dutta","doi":"10.3390/antibiotics13090910","DOIUrl":"https://doi.org/10.3390/antibiotics13090910","url":null,"abstract":"<p><p>Chronic wounds are a major health problem because of delayed healing, causing hardships for the patient. The infection present in these wounds plays a role in delayed wound healing. Silver wound dressings have been used for decades, beginning in the 1960s with silver sulfadiazine for infection prevention for burn wounds. Since that time, there has been a large number of commercial silver dressings that have obtained FDA clearance. In this review, we examine the literature involving in vitro and in vivo (both animal and human clinical) studies with commercial silver dressings and attempt to glean the important characteristics of these dressings in treating infected wounds. The primary presentation of the literature is in the form of detailed tables. The narrative part of the review focuses on the different types of silver dressings, including the supporting matrix, the release characteristics of the silver into the surroundings, and their toxicity. Though there are many clinical studies of chronic and burn wounds using silver dressings that we discuss, it is difficult to compare the performances of the dressings directly because of the differences in the study protocols. We conclude that silver dressings can assist in wound healing, although it is difficult to provide general treatment guidelines. From a wound dressing point of view, future studies will need to focus on new delivery systems for silver, as well as the type of matrix in which the silver is deposited. Clearly, adding other actives to enhance the antimicrobial activity, including the disruption of mature biofilms is of interest. From a clinical point of view, the focus needs to be on the wound healing characteristics, and thus randomized control trials will provide more confidence in the results. The application of different wound dressings for specific wounds needs to be clarified, along with the application protocols. It is most likely that no single silver-based dressing can be used for all wounds.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11429284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Trichoderma spp. and Kosakonia sp. Both Independently and Combined with Fungicides against Botrytis cinerea on Strawberries. Trichoderma spp.和 Kosakonia sp.单独或与杀真菌剂联合对草莓上灰霉病菌的功效。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-23 DOI: 10.3390/antibiotics13090912
Tom E Schierling, Wolfgang Vogt, Ralf T Voegele, Abbas El-Hasan
{"title":"Efficacy of <i>Trichoderma</i> spp. and <i>Kosakonia</i> sp. Both Independently and Combined with Fungicides against <i>Botrytis cinerea</i> on Strawberries.","authors":"Tom E Schierling, Wolfgang Vogt, Ralf T Voegele, Abbas El-Hasan","doi":"10.3390/antibiotics13090912","DOIUrl":"https://doi.org/10.3390/antibiotics13090912","url":null,"abstract":"<p><p><b>Background:</b> The ascomycete <i>Botrytis cinerea</i> is a major pathogen of strawberry, often causing grey mold and significant yield losses. Its management has largely relied on chemical fungicides, which, while effective, can lead to resistant pathogens and harm to non-target organisms and pose health risks. <b>Objectives:</b> This study explored a strategy for minimizing chemical usage by combining biocontrol agents (BCAs) with half-strength fungicide input. <b>Results:</b> In vitro results of fungicide-amended culture plates indicated that the presence of 625 µg mL<sup>-1</sup> Azoxystrobin exhibited no growth inhibition of <i>T. atroviride</i> T19 and <i>T. harzianum</i> T16 but increased conidial density of T16 by 90%. Copper (750 µg mL<sup>-1</sup>) did not suppress the growth of <i>T. virens</i> TVSC or T16 but rather promoted it by 9.5% and 6%, respectively. Additionally, copper increased T16 sporulation by 1.4-fold. Greenhouse trials demonstrated that combining T23 with half-strength Azoxystrobin was as effective as the full dosage in suppressing flower rot. Among the antagonists assessed, <i>Kosakonia</i> sp. exhibited the lowest incidence of fruit rot, whereas T23 resulted in a moderate incidence. Moreover, the combination of T16 or <i>Kosakonia</i> sp. with half-strength copper was almost as effective as the full dosage in reducing fruit rot. <b>Conclusions:</b> Our findings suggest integrating these BCAs in the sustainable management of grey mold in strawberries.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insight into Romanian Wild-Grown Heracleum sphondylium: Development of a New Phytocarrier Based on Silver Nanoparticles with Antioxidant, Antimicrobial and Cytotoxicity Potential. 对罗马尼亚野生生长的刺五加(Heracleum sphondylium)的了解:基于具有抗氧化、抗菌和细胞毒性潜力的银纳米粒子的新型植物载体的开发。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-23 DOI: 10.3390/antibiotics13090911
Adina-Elena Segneanu, Gabriela Vlase, Titus Vlase, Ludovic Everard Bejenaru, George Dan Mogoşanu, Gabriela Buema, Dumitru-Daniel Herea, Maria Viorica Ciocîlteu, Cornelia Bejenaru
{"title":"Insight into Romanian Wild-Grown <i>Heracleum sphondylium</i>: Development of a New Phytocarrier Based on Silver Nanoparticles with Antioxidant, Antimicrobial and Cytotoxicity Potential.","authors":"Adina-Elena Segneanu, Gabriela Vlase, Titus Vlase, Ludovic Everard Bejenaru, George Dan Mogoşanu, Gabriela Buema, Dumitru-Daniel Herea, Maria Viorica Ciocîlteu, Cornelia Bejenaru","doi":"10.3390/antibiotics13090911","DOIUrl":"https://doi.org/10.3390/antibiotics13090911","url":null,"abstract":"<p><p><b>Background</b>: <i>Heracleum sphondylium</i>, a medicinal plant used in Romanian ethnopharmacology, has been proven to have remarkable biological activity. The escalating concerns surrounding antimicrobial resistance led to a special attention being paid to new efficient antimicrobial agents based on medicinal plants and nanotechnology. We report the preparation of a novel, simple phytocarrier that harnesses the bioactive properties of <i>H. sphondylium</i> and silver nanoparticles (HS-Ag system). <b>Methods</b>: <i>H. sphondylium</i>'s low metabolic profile was determined through gas chromatography-mass spectrometry and electrospray ionization-quadrupole time-of-flight-mass spectrometry. The morphostructural properties of the innovative phytocarrier were analyzed by X-ray diffraction, Fourier-transform infrared spectroscopy, Raman spectroscopy, dynamic light scattering, scanning electron microscopy, and energy-dispersive X-ray spectroscopy. The antioxidant activity was evaluated using total phenolic content, ferric reducing antioxidant power, and 2,2-diphenyl-1-picrylhydrazyl (DPPH) in vitro assays. The antimicrobial activity screening against <i>Staphylococcus aureus</i>, <i>Bacillus subtilis</i>, <i>Pseudomonas aeruginosa</i>, and <i>Escherichia coli</i> was conducted using the agar well diffusion method. The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay estimated the in vitro potential cytotoxicity on normal human dermal fibroblasts (NHDF) and cervical cancer (HeLa) cells. <b>Results</b>: A total of 88 biomolecules were detected, such as terpenoids, flavonoids, phenolic acids, coumarins, phenylpropanoids, iridoids, amino acids, phytosterols, fatty acids. The HS-Ag phytocarrier heightened efficacy in suppressing the growth of all tested bacterial strains compared to <i>H. sphondylium</i> and exhibited a significant inhibition of HeLa cell viability. <b>Conclusions</b>: The new HS-Ag phytocarrier system holds promise for a wide range of medical applications. The data confirm the capacity to augment the pertinent theoretical understanding in the innovative field of antimicrobial agents.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant Acinetobacter baumannii Infections-A Meta-Analysis. 比较基于头孢哌酮/舒巴坦和非基于头孢哌酮/舒巴坦的治疗方案在多重耐药鲍曼不动杆菌感染患者中的疗效--一项 Meta 分析。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-23 DOI: 10.3390/antibiotics13090907
Chienhsiu Huang, Lichen Lin, Sufang Kuo
{"title":"Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant <i>Acinetobacter baumannii</i> Infections-A Meta-Analysis.","authors":"Chienhsiu Huang, Lichen Lin, Sufang Kuo","doi":"10.3390/antibiotics13090907","DOIUrl":"https://doi.org/10.3390/antibiotics13090907","url":null,"abstract":"<p><p>The addition of sulbactam restores the complete range of cefoperazone activity against bacteria and extends its spectrum of action to include the <i>Acinetobacter</i> species. The effectiveness of cefoperazone/sulbactam against multiresistant <i>Acinetobacter baumannii</i> has not been investigated. The purpose of the current meta-analysis was to compare the efficacy of cefoperazone/sulbactam-based therapeutic regimens and non-cefoperazone/sulbactam-based therapeutic regimens in the treatment of multiresistant <i>Acinetobacter baumannii</i> infections. The current meta-analysis of 10 retrospective studies provides evidence that cefoperazone/sulbactam-based therapeutic regimens are superior to non-cefoperazone/sulbactam-based therapeutic regimens in terms of 30-day mortality and clinical improvement in patients with multiresistant <i>Acinetobacter baumannii</i> infections. The risk of mortality was reduced by 38% among multiresistant <i>Acinetobacter baumannii</i> infections in patients who received cefoperazone/sulbactam-based therapeutic regimens. The cefoperazone/sulbactam-based combination therapy was superior to the cefoperazone/sulbactam monotherapy in terms of 30-day mortality when both therapeutic regimens were compared to the tigecycline monotherapy in patients with multiresistant <i>Acinetobacter baumannii</i> infections.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428705/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial Effects of Metal Coatings or Physical, Chemical Modifications of Titanium Dental Implant Surfaces for Prevention of Peri-Implantitis: A Systematic Review of In Vivo Studies. 金属涂层或钛牙种植体表面的物理、化学修饰对预防种植体周围炎的抗菌效果:体内研究的系统回顾。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-23 DOI: 10.3390/antibiotics13090908
Maria Gkioka, Xiaohui Rausch-Fan
{"title":"Antimicrobial Effects of Metal Coatings or Physical, Chemical Modifications of Titanium Dental Implant Surfaces for Prevention of Peri-Implantitis: A Systematic Review of In Vivo Studies.","authors":"Maria Gkioka, Xiaohui Rausch-Fan","doi":"10.3390/antibiotics13090908","DOIUrl":"https://doi.org/10.3390/antibiotics13090908","url":null,"abstract":"<p><p><b>Introduction:</b> Peri-implantitis poses a significant challenge for implant dentistry due to its association with bacterial colonization on implant surfaces and the complexity of its management. This systematic review aims to assess evidence from in vivo studies regarding the antimicrobial efficacy of titanium (Ti) dental implant surfaces following physical/chemical modifications or the application of various metal element coatings in preventing bacterial growth associated with peri-implantitis. <b>Materials and Methods:</b> A literature review was conducted across four scientific databases (PubMed, Embase, Scopus, Web of Science), encompassing in vivo studies published between 2013 and 2024, and 18 reports were included in the systematic review. <b>Results:</b> The findings suggest that titanium dental implant surfaces, following physical/chemical modifications and metal element coatings, exhibit antimicrobial effects against bacteria associated with peri-implantitis in humans and various animal models. <b>Conclusions:</b> The reviewed studies indicated a reduction in bacterial colonization, diminished biofilm formation, and decreased signs of inflammation in the peri-implant tissues, which provides evidence that physical/chemical alterations on titanium dental implant surfaces or metal element coatings, like silver (Ag), zinc (Zn), magnesium (Mg), and copper (Cu), demonstrate antimicrobial properties in in vivo studies. However, caution is warranted when translating findings to clinical practice due to methodological disparities and high bias risks. Further larger-scale clinical trials are imperative to assess their long-term efficacy and validate their clinical applicability.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Vivo Effect of Halicin on Methicillin-Resistant Staphylococcus aureus-Infected Caenorhabditis elegans and Its Clinical Potential. 卤素对感染耐甲氧西林金黄色葡萄球菌的秀丽隐杆线虫的体内效应及其临床应用潜力
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-23 DOI: 10.3390/antibiotics13090906
Li-Ting Kao, Tsung-Ying Yang, Wei-Chun Hung, Wei-Te Yang, Pu He, Bo-Xuan Chen, Yu-Chi Wang, Shiou-Sheng Chen, Yu-Wei Lai, Hsian-Yu Wang, Sung-Pin Tseng
{"title":"In Vivo Effect of Halicin on Methicillin-Resistant <i>Staphylococcus aureus</i>-Infected <i>Caenorhabditis elegans</i> and Its Clinical Potential.","authors":"Li-Ting Kao, Tsung-Ying Yang, Wei-Chun Hung, Wei-Te Yang, Pu He, Bo-Xuan Chen, Yu-Chi Wang, Shiou-Sheng Chen, Yu-Wei Lai, Hsian-Yu Wang, Sung-Pin Tseng","doi":"10.3390/antibiotics13090906","DOIUrl":"https://doi.org/10.3390/antibiotics13090906","url":null,"abstract":"<p><p>Recently, the high proportion of methicillin-resistant <i>Staphylococcus aureus</i> infections worldwide has highlighted the urgent need for novel antibiotics to combat this crisis. The recent progress in computational techniques for use in health and medicine, especially artificial intelligence (AI), has created new and potential approaches to combat antibiotic-resistant bacteria, such as repurposing existing drugs, optimizing current agents, and designing novel compounds. Halicin was previously used as a diabetic medication, acting as a c-Jun N-terminal protein kinase (JNK) inhibitor, and has recently demonstrated unexpected antibacterial activity. Although previous efforts have highlighted halicin's potential as a promising antibiotic, evidence regarding its effectiveness against clinical strains remains limited, with insufficient proof of its clinical applicability. In this study, we sought to investigate the antibacterial activity of halicin against MRSA clinical strains to validate its clinical applicability, and a <i>C. elegans</i> model infected by MRSA was employed to evaluate the in vivo effect of halicin against MRSA. Our findings revealed the antibacterial activity of halicin against methicillin-resistant <i>S. aureus</i> clinical strains with MICs ranging from 2 to 4 µg/mL. Our study is also the first work to evaluate the in vivo effect of halicin against <i>S. aureus</i> using a <i>C. elegans</i> model, supporting its further development as an antibiotic.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11429483/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clarithromycin Modulates Neutrophilic Inflammation Induced by Prevotella intermedia in Human Airway Epithelial Cells. 克拉霉素可调节人气道上皮细胞中中前驱菌诱导的中性粒细胞炎症
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-23 DOI: 10.3390/antibiotics13090909
Naoki Iwanaga, Ayaka Ota, Hiroki Ashizawa, Yuya Ito, Tatsuro Hirayama, Masataka Yoshida, Kazuaki Takeda, Shotaro Ide, Masato Tashiro, Naoki Hosogaya, Noriho Sakamoto, Takahiro Takazono, Kosuke Kosai, Mariko Naito, Yoshimasa Tanaka, Kazuhiro Yatera, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae
{"title":"Clarithromycin Modulates Neutrophilic Inflammation Induced by <i>Prevotella intermedia</i> in Human Airway Epithelial Cells.","authors":"Naoki Iwanaga, Ayaka Ota, Hiroki Ashizawa, Yuya Ito, Tatsuro Hirayama, Masataka Yoshida, Kazuaki Takeda, Shotaro Ide, Masato Tashiro, Naoki Hosogaya, Noriho Sakamoto, Takahiro Takazono, Kosuke Kosai, Mariko Naito, Yoshimasa Tanaka, Kazuhiro Yatera, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae","doi":"10.3390/antibiotics13090909","DOIUrl":"https://doi.org/10.3390/antibiotics13090909","url":null,"abstract":"<p><p><b>Objectives:</b> In the present study, we aimed to clarify the mechanisms by which periodontal pathogens, particularly <i>Prevotella intermedia</i>, induce severe neutrophilic inflammation. In addition, we aimed to test the efficacy of macrolides, which has not been resolved in the neutrophilic inflammation induced by <i>P. intermedia</i>. <b>Methods:</b> NCl-H292 human airway epithelial cells were pre-incubated with clarithromycin for 2 h before incubation with <i>P. intermedia</i> supernatants. Then, C-X-C motif chemokine ligand 8 (<i>CXCL8</i>) transcription and interleukin (IL)-8 production were measured. To elucidate the signaling pathway, mitogen-activated protein kinase inhibitors were added to the cell culture, and the cells were subjected to Western blotting. <b>Results:</b><i>P. intermedia</i> supernatants promoted <i>CXCL8</i> transcription and IL-8 production, and the reactions were significantly suppressed by clarithromycin pretreatment. Only trametinib, the selective mitogen-activated extracellular signal-regulated kinase inhibitor, downregulated <i>CXCL8</i> transcription and IL-8 production. Furthermore, Western blotting revealed that stimulation with <i>P. intermedia</i> supernatants specifically induces extracellular signal-regulated kinases (ERK) 1/2 phosphorylation, which is suppressed by clarithromycin pretreatment. Notably, the interference analysis revealed that ERK3 might be dispensable for IL-8 production under the stimulation of <i>P. intermedia</i> supernatants. <b>Conclusions:</b> Our results provide new insight into the mechanism underlying <i>P. intermedia</i>-induced production of IL-8 from human airway epithelial cells. Furthermore, macrolides might have therapeutic potential in regulating periodontal pathogen-induced neutrophilic inflammation in the lungs.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11429484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Contribution of Dairy Bedding and Silage to the Dissemination of Genes Coding for Antimicrobial Resistance: A Narrative Review. 奶牛垫料和青贮饲料对抗菌药耐药性基因传播的贡献:叙述性综述。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-22 DOI: 10.3390/antibiotics13090905
Armin Tarrah, Dong Zhang, Pariya Darvishzadeh, Gisèle LaPointe
{"title":"The Contribution of Dairy Bedding and Silage to the Dissemination of Genes Coding for Antimicrobial Resistance: A Narrative Review.","authors":"Armin Tarrah, Dong Zhang, Pariya Darvishzadeh, Gisèle LaPointe","doi":"10.3390/antibiotics13090905","DOIUrl":"https://doi.org/10.3390/antibiotics13090905","url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) is a concern in the dairy industry. Recent studies have indicated that bedding serves as a reservoir for antimicrobial-resistant bacteria and antimicrobial-resistance genes (ARGs), while silage has been proposed as another possible source. The impact of AMR in dairy farming can be significant, resulting in decreased productivity and economic losses for farmers. Several studies have highlighted the safety implications of AMR bacteria and genes in bedding and silage, emphasizing the need for further research on how housing, bedding, and silage management affect AMR in farm environments. Exposure to sub-lethal concentrations of antibiotics, such as those from contaminated bedding and silage, can prompt bacteria to develop resistance mechanisms. Thus, even if antimicrobial usage is diminished, ARGs may be maintained in the dairy farm environment. By implementing proactive measures to tackle AMR in dairy farming, we can take steps to preserve the health and productivity of dairy cattle while also protecting public health. This involves addressing the prudent use of antibiotics during production and promoting animal welfare, hygiene, and management practices in bedding and farm environments to minimize the risk of AMR development and spread. This narrative review compiles the growing research, positioning the contribution of bedding and silage to the prevalence and dissemination of AMR, which can elicit insights for researchers and policymakers.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Decade of Antimicrobial Resistance in Human and Animal Campylobacter spp. Isolates. 人类和动物弯曲杆菌属菌株对抗菌剂耐药性的十年。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-21 DOI: 10.3390/antibiotics13090904
Rita Barata, Maria José Saavedra, Gonçalo Almeida
{"title":"A Decade of Antimicrobial Resistance in Human and Animal <i>Campylobacter</i> spp. Isolates.","authors":"Rita Barata, Maria José Saavedra, Gonçalo Almeida","doi":"10.3390/antibiotics13090904","DOIUrl":"https://doi.org/10.3390/antibiotics13090904","url":null,"abstract":"<p><p><b>Objectives</b>: <i>Campylobacter</i> spp. remain a leading cause of bacterial gastroenteritis worldwide, with resistance to antibiotics posing significant challenges to treatment and public health. This study examines profiles in antimicrobial resistance (AMR) for <i>Campylobacter</i> isolates from human and animal sources over the past decade. <b>Methods</b>: We conducted a comprehensive review of resistance data from studies spanning ten years, analyzing profiles in resistance to key antibiotics, ciprofloxacin (CIP), tetracycline (TET), erythromycin (ERY), chloramphenicol (CHL), and gentamicin (GEN). Data were collated from various regions to assess global and regional patterns of resistance. <b>Results</b>: The analysis reveals a concerning trend of increasing resistance patterns, particularly to CIP and TET, across multiple regions. While resistance to CHL and GEN remains relatively low, the high prevalence of CIP resistance has significantly compromised treatment options for campylobacteriosis. Discrepancies in resistance patterns were observed between human and animal isolates, with variations across different continents and countries. Notably, resistance to ERY and CHL showed regional variability, reflecting potential differences in antimicrobial usage and management practices. <b>Conclusions</b>: The findings underscore the ongoing challenge of AMR in <i>Campylobacter</i>, highlighting the need for continued surveillance and research. The rising resistance prevalence, coupled with discrepancies in resistance patterns between human and animal isolates, emphasize the importance of a One Health approach to address AMR. Enhanced monitoring, novel treatment strategies, and global cooperation are crucial for mitigating the impact of resistance and ensuring the effective management of <i>Campylobacter</i>-related infections.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11429304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opportunities for Laboratory Testing to Inform Antimicrobial Use for Bovine Respiratory Disease: Application of Information Quality Value Stream Maps in Commercial Feedlots. 实验室检测为牛呼吸道疾病抗菌药使用提供信息的机会:商业饲养场中信息质量价值流图的应用。
IF 4.3 2区 医学
Antibiotics-Basel Pub Date : 2024-09-21 DOI: 10.3390/antibiotics13090903
Simon J G Otto, Colleen M Pollock, Jo-Anne Relf-Eckstein, Lianne McLeod, Cheryl L Waldner
{"title":"Opportunities for Laboratory Testing to Inform Antimicrobial Use for Bovine Respiratory Disease: Application of Information Quality Value Stream Maps in Commercial Feedlots.","authors":"Simon J G Otto, Colleen M Pollock, Jo-Anne Relf-Eckstein, Lianne McLeod, Cheryl L Waldner","doi":"10.3390/antibiotics13090903","DOIUrl":"https://doi.org/10.3390/antibiotics13090903","url":null,"abstract":"<p><strong>Background/objectives: </strong>The implementation of information quality value stream maps (IQ-VSMs) in food animal production systems can increase our understanding of the opportunities and challenges when using laboratory testing for antimicrobial resistance (AMR) to support antimicrobial stewardship (AMS). Our objectives were to (1) explore the implementation of information quality value stream mapping as a continuous improvement tool to inform decisions for bovine respiratory disease (BRD) management and AMS and (2) apply the information quality dimensions to identified Kaizen opportunities for the integration of laboratory data into BRD management systems to assess the appropriateness of BRD treatment plans in western Canadian feedlot production.</p><p><strong>Methods: </strong>A 'Current State' IQ-VSM outlined the processes, available information, information processing steps, and control decisions contributing to BRD management and treatment in commercial western Canadian feedlots, recognizing that laboratory BRD pathogens and AMR data are typically not part of BRD management.</p><p><strong>Results: </strong>The 'Future State' IQ-VSM incorporated Kaizen opportunities for improvement, including (i) the strategic collection of respiratory samples from representative samples of calves for laboratory analysis, regardless of clinical BRD status, (ii) compilation of laboratory data at the pen and feedlot levels, and (iii) analysis of pen- and feedlot-level laboratory data to inform the veterinarian's assessment of the appropriateness of current BRD treatment plans.</p><p><strong>Conclusions: </strong>The IQ-VSMs provided a valuable framework to visualize the integration of BRD pathogen and AMR laboratory data to support AMS and address any potential future testing requirements.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信